Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) Enterprise Value (2022 - 2026)

Nexalin Technology has reported Enterprise Value over the past 5 years, most recently at -$6.1 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 76.35% year-over-year to -$6.1 million; the TTM value through Dec 2025 reached -$6.1 million, down 76.35%, while the annual FY2025 figure was -$6.1 million, 76.35% down from the prior year.
  • Enterprise Value for Q4 2025 was -$6.1 million at Nexalin Technology, down from -$4.4 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$661778.0 in Q4 2021 and troughed at -$9.0 million in Q3 2024.
  • A 5-year average of -$4.6 million and a median of -$4.7 million in 2023 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: plummeted 956.84% in 2022 and later surged 81.93% in 2024.
  • Year by year, Enterprise Value stood at -$661778.0 in 2021, then plummeted by 956.84% to -$7.0 million in 2022, then soared by 32.28% to -$4.7 million in 2023, then rose by 26.53% to -$3.5 million in 2024, then crashed by 76.35% to -$6.1 million in 2025.
  • Business Quant data shows Enterprise Value for NXL at -$6.1 million in Q4 2025, -$4.4 million in Q3 2025, and -$5.8 million in Q2 2025.